177 related articles for article (PubMed ID: 28266806)
1. A pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorder.
Hirosawa T; Kikuchi M; Ouchi Y; Takahashi T; Yoshimura Y; Kosaka H; Furutani N; Hiraishi H; Fukai M; Yokokura M; Yoshikawa E; Bunai T; Minabe Y
Autism Res; 2017 May; 10(5):821-828. PubMed ID: 28266806
[TBL] [Abstract][Full Text] [Related]
2. Oxytocin effects on emotional response to others' faces via serotonin system in autism: A pilot study.
Fukai M; Hirosawa T; Kikuchi M; Ouchi Y; Takahashi T; Yoshimura Y; Miyagishi Y; Kosaka H; Yokokura M; Yoshikawa E; Bunai T; Minabe Y
Psychiatry Res Neuroimaging; 2017 Sep; 267():45-50. PubMed ID: 28738293
[TBL] [Abstract][Full Text] [Related]
3. Markers for the central serotonin system correlate to verbal ability and paralinguistic social voice processing in autism spectrum disorder.
Yoshimura Y; Kikuchi M; Saito DN; Hirosawa T; Takahashi T; Munesue T; Kosaka H; Naito N; Ouchi Y; Minabe Y
Sci Rep; 2020 Sep; 10(1):14558. PubMed ID: 32883965
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin Fails to Recruit Serotonergic Neurotransmission in the Autistic Brain.
Lefevre A; Mottolese R; Redouté J; Costes N; Le Bars D; Geoffray MM; Leboyer M; Sirigu A
Cereb Cortex; 2018 Dec; 28(12):4169-4178. PubMed ID: 29045584
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic signatures associated with plasma oxytocin levels in children and adolescents with autism spectrum disorder.
Siecinski SK; Giamberardino SN; Spanos M; Hauser AC; Gibson JR; Chandrasekhar T; Trelles MDP; Rockhill CM; Palumbo ML; Cundiff AW; Montgomery A; Siper P; Minjarez M; Nowinski LA; Marler S; Kwee LC; Shuffrey LC; Alderman C; Weissman J; Zappone B; Mullett JE; Crosson H; Hong N; Luo S; She L; Bhapkar M; Dean R; Scheer A; Johnson JL; King BH; McDougle CJ; Sanders KB; Kim SJ; Kolevzon A; Veenstra-VanderWeele J; Hauser ER; Sikich L; Gregory SG
Autism Res; 2023 Mar; 16(3):502-523. PubMed ID: 36609850
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin and Serotonin Brain Mechanisms in the Nonhuman Primate.
Lefevre A; Richard N; Jazayeri M; Beuriat PA; Fieux S; Zimmer L; Duhamel JR; Sirigu A
J Neurosci; 2017 Jul; 37(28):6741-6750. PubMed ID: 28607170
[TBL] [Abstract][Full Text] [Related]
7. A link between oxytocin and serotonin in humans: supporting evidence from peripheral markers.
Marazziti D; Baroni S; Giannaccini G; Betti L; Massimetti G; Carmassi C; Catena-Dell'Osso M
Eur Neuropsychopharmacol; 2012 Aug; 22(8):578-83. PubMed ID: 22297159
[TBL] [Abstract][Full Text] [Related]
8. Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease.
Ouchi Y; Yoshikawa E; Futatsubashi M; Yagi S; Ueki T; Nakamura K
J Nucl Med; 2009 Aug; 50(8):1260-6. PubMed ID: 19617327
[TBL] [Abstract][Full Text] [Related]
9. Amygdala-Hippocampal Connectivity Is Associated With Endogenous Levels of Oxytocin and Can Be Altered by Exogenously Administered Oxytocin in Adults With Autism.
Alaerts K; Bernaerts S; Vanaudenaerde B; Daniels N; Wenderoth N
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jul; 4(7):655-663. PubMed ID: 30846366
[TBL] [Abstract][Full Text] [Related]
10. Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei: An ultra-high resolution PET-MRI study.
Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Joo YH; Kim YB; Cho ZH
Brain Res; 2015 Dec; 1629():63-71. PubMed ID: 26459992
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin and Animal Models for Autism Spectrum Disorder.
Wagner S; Harony-Nicolas H
Curr Top Behav Neurosci; 2018; 35():213-237. PubMed ID: 28864977
[TBL] [Abstract][Full Text] [Related]
12. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders.
Tachibana M; Kagitani-Shimono K; Mohri I; Yamamoto T; Sanefuji W; Nakamura A; Oishi M; Kimura T; Onaka T; Ozono K; Taniike M
J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):123-7. PubMed ID: 23480321
[TBL] [Abstract][Full Text] [Related]
13. Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study.
Frick A; Åhs F; Engman J; Jonasson M; Alaie I; Björkstrand J; Frans Ö; Faria V; Linnman C; Appel L; Wahlstedt K; Lubberink M; Fredrikson M; Furmark T
JAMA Psychiatry; 2015 Aug; 72(8):794-802. PubMed ID: 26083190
[TBL] [Abstract][Full Text] [Related]
14. The serotonin system in autism spectrum disorder: From biomarker to animal models.
Muller CL; Anacker AMJ; Veenstra-VanderWeele J
Neuroscience; 2016 May; 321():24-41. PubMed ID: 26577932
[TBL] [Abstract][Full Text] [Related]
15. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
Frankle WG; Robertson B; Maier G; Paris J; Asmonga D; May M; Himes ML; Mason NS; Mathis CA; Narendran R
Synapse; 2018 Mar; 72(3):. PubMed ID: 29216407
[TBL] [Abstract][Full Text] [Related]
16. Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up.
Alaerts K; Steyaert J; Vanaudenaerde B; Wenderoth N; Bernaerts S
Eur Neuropsychopharmacol; 2021 Feb; 43():147-152. PubMed ID: 33309460
[TBL] [Abstract][Full Text] [Related]
17. Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism.
Moy SS; Teng BL; Nikolova VD; Riddick NV; Simpson CD; Van Deusen A; Janzen WP; Sassano MF; Pedersen CA; Jarstfer MB
Neuropharmacology; 2019 Jan; 144():301-311. PubMed ID: 30399367
[TBL] [Abstract][Full Text] [Related]
18. Oxytocin plasma concentrations in children and adolescents with autism spectrum disorder: correlation with autistic symptomatology.
Taurines R; Schwenck C; Lyttwin B; Schecklmann M; Jans T; Reefschläger L; Geissler J; Gerlach M; Romanos M
Atten Defic Hyperact Disord; 2014 Sep; 6(3):231-9. PubMed ID: 24989441
[TBL] [Abstract][Full Text] [Related]
19. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.
Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Lee JE; Cho ZH; Kim YB
Psychiatry Res; 2015 Jan; 231(1):50-7. PubMed ID: 25465315
[TBL] [Abstract][Full Text] [Related]
20. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [
Kim JH; Kim JH; Son YD; Joo YH; Lee SY; Kim HK; Woo MK
Schizophr Res; 2017 Apr; 182():55-65. PubMed ID: 27760700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
